Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next?

Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next?

Show other versions (1)

Bibliographic Details
Main Authors:	E. Una Cidon, P. Alonso, B. Masters
Format:	Article
Language:	English
Published:	SAGE Publishing 2016-04-01
Series:	Clinical Medicine Insights: Oncology
Online Access:	http://www.la-press.com/markers-of-response-to-antiangiogenic-therapies-in-colorectal-cancer-w-article-a5568

Similar Items

Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where are We Now and What should be Next?
by: E. Una Cidon, et al.
Published: (2016-01-01)

COVID-19 – Where should we go now?
by: Claire Allen, et al.
Published: (2020-09-01)

Colorectal Cancer Biomarkers: Where Are We Now?
by: Maria Gonzalez-Pons, et al.
Published: (2015-01-01)

Where we have been, where we are now, and where we might be heading : Where next for the coaching relationship?
by: Alanna O'Broin
Published: (2016-12-01)

Pulse Crop Genetics for a Sustainable Future: Where We Are Now and Where We Should Be Heading
by: Nurul Amylia Sahruzaini, et al.
Published: (2020-04-01)

Dietary Supplement for Core Symptoms of Autism Spectrum Disorder: Where Are We Now and Where Should We Go?
by: Yong-Jiang Li, et al.
Published: (2017-08-01)

Pharmacological Therapy for COVID-19: Where Are We Now and Where Are We Going?
by: Baha Eldin Hassan Juma, et al.
Published: (2020-04-01)

Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now?
by: Francesco Mannavola, et al.
Published: (2019-06-01)

Smart fertilizers: what should we mean and where should we go?
by: Giorgia Raimondi, et al.
Published: (2021-03-01)

Export performance research: Where should we go next?
by: Piotr Trąpczyński, et al.
Published: (2021-03-01)

Percutaneous coronary intervention vs. cardiac surgery in diabetic patients. Where are we now and where should we be going?
by: George Kassimis, et al.
Published: (2017-05-01)

Editorial: E-learning and Knowledge Management in the Early Years: Where Are We and Where Should We Go
by: Hui Li, et al.
Published: (2009-12-01)

Tregs: Where We Are and What Comes Next?
by: Hai Zhao, et al.
Published: (2017-11-01)

Capecitabine versus 5-fluorouracil in colorectal cancer: where are we now?
by: Lakshmi Chintala, et al.
Published: (2011-06-01)

Broadening Our Understanding of Hurricanes and Forests on the Caribbean Island of Puerto Rico: Where and What Should We Study Now?
by: Tania López-Marrero, et al.
Published: (2019-08-01)

Anticytokine therapy for periodontal diseases: Where are we now?
by: Waykole Yogesh, et al.
Published: (2009-01-01)

Onchodermatitis: Where Are We Now?
by: Michele E. Murdoch
Published: (2018-09-01)

Teleophthalmology: where are we now?
by: Ana Beatriz D. Grisolia, et al.

Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be?
Published: (2019)

Teleneurorehabilitation in the COVID-19 Era: What Are We Doing Now and What will We Do Next?
by: Rocco Salvatore Calabrò
Published: (2021-02-01)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
by: Gordon A. McLorie
Published: (2008-01-01)

Myocardial T1 mapping: where are we now and where are we going?
by: Abdel-Gadir A, et al.
Published: (2014-11-01)

Hip fracture rehabilitation: where are we now and where are we going?
by: Auais, Mohammad
Published: (2013)

Anti-cytokine therapy in fibrosing alveolitis: where are we now?
by: Millar Ann
Published: (2000-06-01)

Editorial: Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be?
by: Błazej Misiak, et al.
Published: (2019-01-01)

Microbiota and Obesity: Where Are We Now?
by: Andrea Ballini, et al.
Published: (2020-11-01)

Intracranial Atherosclerosis: Where Are We Now?
by: Jong S. Kim
Published: (2017-09-01)

Tuberculosis elimination: where are we now?
by: Alberto Matteelli, et al.
Published: (2018-06-01)

WHERE ARE WE NOW IN THE TREATMENT OF HEMORRHOIDS
by: Vladimir Čuk, et al.
Published: (2015-03-01)

Security training: where are we now?
by: Koenraad Van Brabant
Published: (1999-04-01)

Depression research: where are we now?
by: Lee Saebom, et al.
Published: (2010-03-01)

Renin research: where are we now?
by: Pierre Corvol, et al.
Published: (2008-03-01)

Editorial: This Is Where We Dance Now
by: Harmony Bench, et al.
Published: (2021-07-01)

Standard Chartered Bank: where should it go now?.
Published: (1994)

Reflection for the undergraduate on writing in the portfolio: where are we now and where are we going?
by: MOHAMED H AHMED
Published: (2018-07-01)

Yellow fever control in Cameroon: Where are we now and where are we going?
by: Mimbouga Julienne, et al.
Published: (2008-02-01)

Brazilian Science and Research Integrity: Where are We? What Next?
by: Sonia M.R. Vasconcelos, et al.
Published: (2015-06-01)

Primary motor cortex and fast feedback responses to mechanical perturbations: a primer on what we know now and some suggestions on what we should find out next
by: J. Andrew ePruszynski
Published: (2014-09-01)

Entomology in South Africa: Where do we come from, where are we now and where are we going?
by: Jan H. Giliomee
Published: (2013-01-01)

Stem cell therapy in diabetic foot patients: where are we now?
by: Stanley Kirana, et al.
Published: (2011-05-01)